Lundbeck retreats from dozens of markets, slashing staff

Lundbeck retreats from dozens of markets, slashing staff

Lundbeck has announced a major change to its commercial strategy, withdrawing from 27 markets and handing day-to-day operations to partners.

Lundbeck to transfer commercial drugs to three partners in 27 markets

The Danish biopharma is handing off marketing responsibilities to three companies — Swixx Group, Zuellig Pharma and NewBridge Pharmaceuticals — in certain areas of Asia, Europe, South America, North Africa and the Middle East.